- Details
- Description
Strength:
200 mg
Composition:
Ribociclib 200mg
Treatment:
HR-positive, HER2-negative advanced or metastatic breast cancer
Form:
tablets
Brand:
KISQALI
Quantity Unit:
Tablets/pack
Manufacturer:
Novartis
KISQALI 200mg (Ribociclib) is a prescription anticancer medicine containing ribociclib, a CDK4/6 inhibitor. It is used in combination with other treatments for certain types of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer. Ribociclib works by helping slow the growth and division of cancer cells. Use only under the supervision of a qualified healthcare professional.
